CLL Epigenetics

Epigenetic changes in cancer and in response to environmental exposures. “The true measure of a man is how he treats someone who can do him absolutely no good”

[Blood Cancer UK Research @BloodCancer_Res]

🚨 Applications are currently open for our Transformational Research Awards

We're funding ambitious blood cancer research, with awards of up to £1.5m over 5 years

📅 EOI deadline: 4 June 2026, 3pm

Find out more and apply:
https://t.co/FShr4Swp6o

[Larry the Cat @Number10cat]

"Whether Starmer stays or goes we can all agree that me being fed is the most important thing"

[UK Chronic Lymphocytic Leukaemia (CLL) Forum @UkCllforum]

All systems go.
Ready to begin a full-on CLL scientific day in central London.
#CLL

[Teif Lab @TeifLab]

Nucleosome aficionados! Our new review "Nucleosome spacing across cell types, diseases, and ages" is out in NAR: https://t.co/Z1TgEYxBH8

A huge effort to pull together what we’ve learned about nucleosome spacing in many systems. Enjoy!
#nucleosomics #nucleosome #chromatin #cfDNA

[Stathis Giotis @stathisgiotis]

Delighted that my PhD student @Tukur_Abdallah has successfully passed his PhD viva. His PhD examined the temperature dependency of seasonal coronaviruses; excellent work and a great achievement.
Many thanks to examiners: Qibo Zhang and
Timothy Barrow for acting
Well done, Tukur!

[University of Essex @Uni_of_Essex]

An incredible student experience and inspirational teaching fuelled by world-leading research means we’re 12th in the UK according to the Guardian University Guide 2026.

We’re also 1st for drama and in the top 10 for many other subjects.

https://t.co/P9beRIeL7s

[Cambridge Cancer Research Hospital @CambCancer]

Many congratulations to Professor Rebecca Fitzgerald, who has been appointed as the new Head of the Department of Oncology @Cambridge_Uni from 1st October.

Professor Fitzgerald will lead the Early Cancer Institute Research Clinic at Cambridge Cancer Research Hospital.

[Blood Journals Portfolio @BloodPortfolio]

MRD-guided I+V for R/R CLL reduces toxicity, with OS and PFS comparable with other available regimens. https://t.co/spteLANkDd #clinicaltrialsandobservations #lymphoidneoplasia

[W. Keith Tan @DrWKTan]

1/8 🎉Thrilled to share our landmark study now published in @TheLancet on a capsule sponge surveillance strategy for Barrett's oesophagus https://t.co/PR1hyLoAfl
presented at the @BritSocGastro, Glasgow @Cambridge_Uni @EarlyCancerCam @addenbrookes @CR_UK @RFitzgerald_lab

[University of Essex @Uni_of_Essex]

Essex has been shortlisted for two prestigious national @innovateuk Knowledge Transfer Partnerships (KTP) Awards.

The awards recognise the work Essex does with businesses, charities and organisations around the country.

Find out more: https://t.co/d5ynitf2U9

[Cambridge University @Cambridge_Uni]

'Pill-on-a-thread' tests could replace endoscopies for half of all patients with Barrett’s oesophagus, a precursor to oesophageal cancer.

The capsule sponge test - developed @EarlyCancerCam @CRUKCamCentre - is less invasive and can be carried out by nurses and at GP practices, reducing the burden on NHS resources.

Hear what a difference it has already made to patients: https://t.co/6u3qgWTrIs

#ChangingTheStoryOfCancer

[Rebecca Fitzgerald Lab @RFitzgerald_lab]

Just published in @TheLancet! We show that the capsule sponge improves Barrett's surveillance, helping prioritize high-risk patients for endoscopy & offering a more efficient, patient-friendly approach for low-risk individuals. https://t.co/Fs5vlq6yxT
#GITwitter #Earlydetection

[UK Chronic Lymphocytic Leukaemia (CLL) Forum @UkCllforum]

🚨🚨Program is out for our Autumn @UkCllforum clinical sciences meeting.
OCTOBER 3rd 2025
Cavendish Conference centre - London
Registration is now open

[CLLSA @CLLSupport]

Thank you to all our supporters, we couldn't provide the services we do without your help. Donations to CLL Support can be made here: https://t.co/xLdamIk7YA

[CLLSA @CLLSupport]

Find out more about Mark White's open water swim in aid of CLL Support on his JustGiving page:

https://t.co/DOxnTOL5qX

[Rebecca Fitzgerald Lab @RFitzgerald_lab]

What does the BOSS trial mean for the future of BE surveillance? We share key lessons learned and outline new directions for improving patient outcomes. Dive into our latest commentary here:
https://t.co/lKSumZtOHZ @petersasieni
#Oncology #GIresearch #Barretts #Surveillance

[Leukaemia UK @LeukUK]

We attended #EHA2025 where major advances in #leukaemia were shared.

🔬 Menin inhibitors show promise in AML
👴 Age shouldn't limit treatment options
🏠 Push for oral, at-home therapies
🧬 T-ALL: 15 subtypes ID’d for personalised care

#BloodCancer #AML #Haematology

[Cambridge University @Cambridge_Uni]

11 Cambridge researchers have been awarded Advanced Grants from the @ERC_Research – the highest number of grants awarded to any institution in this latest funding round.

Explore their research 👉
https://t.co/TxpeOwcfKJ

[Leukaemia UK @LeukUK]

Great news from the UK-led FLAIR trial! A chemo-free combo (ibrutinib + venetoclax) shows significantly better 5-year outcomes for CLL— 94% of patients alive & progression-free. A big step toward kinder, more effective treatments.
https://t.co/8CJb3ZJgtG

[Leukaemia UK @LeukUK]

Huge congrats to our John Goldman Fellow, Dr Simon Mitchell @SiFTW, on the one-year anniversary of the Sussex Cancer Research Centre (SCRC) - an ambitious, collaborative hub supporting new PhD students, pioneering research projects and driving interdisciplinary collaborations. 🎉